Tesmorelin is a synthetic peptide analogue of growth hormone–releasing hormone (GHRH), widely used in controlled in-vitro laboratory studies to investigate GHRH receptor signaling, intracellular cAMP/PKA pathways, and experimental models of the growth hormone (GH) axis.
By mimicking endogenous GHRH (1–44), Tesmorelin enables precise evaluation of receptor activation, downstream signaling cascades, and regulatory mechanisms involved in GH secretion under non-clinical research conditions.
Product name: Tesmorelin
Synonyms: TH9507; GHRH (1–44) analogue
Class: Peptide analogue of growth hormone–releasing hormone
Form: Lyophilised powder
Appearance: White to off-white solid
Note: Physicochemical properties may vary depending on counterion or hydration state
All products are manufactured exclusively for controlled laboratory research and development.
Not for human or animal use.
🧪 Receptor Signalling Studies
Evaluation of GHRH receptor activation
Analysis of ligand–receptor binding and signal transduction
⚗️ cAMP / PKA Pathway Research
Investigation of intracellular second-messenger signaling
Mapping downstream phosphorylation cascades
🧩 Growth Hormone Axis Models
In-vitro simulation of GH regulatory mechanisms
Functional studies of hypothalamic–pituitary signaling
🔒 Peptide Stability & Integrity Testing
Assessment of peptide degradation under experimental conditions
Stability studies across temperature, pH, and enzymatic exposure
📦 Formulation & Delivery Research
Evaluation of peptide behavior in research-grade carriers
Compatibility testing with excipients and delivery systems
🧬 Cell-Based & Molecular Assays
Use in receptor-expressing cell lines
Support for mechanistic and translational research models
